diabetes type 1 and 2
Cannabinoid-1 receptor antagonists in type-2 diabetes.
13
DPP-4 inhibitors in the treatment of type 2 diabetes.
27
Skeletal muscle lipase content and activity in obesity and type 2 diabetes.
6
Preventing and treating kidney disease in patients with type 2 diabetes
19
Skin autofluorescence predicts cancer in subjects with type 2 diabetes
8
Voglibose for prevention of type 2 diabetes mellitus.
3
Thymus dysfunction in the development of type 1 diabetes and endocrine autoimmune diseases
3
Which incretin-based therapy for type 2 diabetes?
7
Addition of incretin therapy to metformin in type 2 diabetes.
3
Pulse pressure and cardiovascular autonomic neuropathy according to duration of type 1 diabetes.
11
Pharmacological management of type 2 diabetes: what's new in 2017?
36
Bariatric surgery in patients with Type 2 diabetes: benefits, risks, indications and perspectives.
8
Dulaglutide (LY-2189265) for the treatment of type 2 diabetes.
32
‘Treatment-resistant’ type 2 diabetes: Which definition for clinical practice?
3
Hyperglycemia, type 2 diabetes, and depressive symptoms: the British Whitehall II study.
13
Preventing, delaying, or masking type 2 diabetes with metformin in the diabetes prevention program?
4
T Cell Populations and Functions Are Altered in Human Obesity and Type 2 Diabetes
20
IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells
9
Job strain as a risk factor for type 2 diabetes: a pooled analysis of 124,808 men and women.: Job Strain and Incident Type 2 Diabetes
27
Thymus and Type 1 diabetes: Where are we now?
1